Contribution of L-Tyrosine to Recovery From Operational Strain on Return From External Operation

NACompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

September 9, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Stress, Psychological
Interventions
BIOLOGICAL

Blood collection

A blood sample will be collected before during and after the treatment.

DRUG

L-Tyrosine 500 Mg

The participants will be administered 4 capsules of L-Tyrosine 500 mg per oral route daily over 1 month.

BEHAVIORAL

Psychological questionnaires

"The participants will fill in several psychological questionnaires before, during and after treatment administration:~* Life Event Checklist~* Moral injury~* Posttraumatic Checklist~* Burnout Assessment Tool~* State-Trait Anger Expression Inventory-2~* Ruminative Response Scale - Reconsidered~* Deployment Risk and Resilience Inventory-2~* Questionnaire about tobacco use"

DEVICE

Photoplethysmography

Photoplethysmography recording will be performed before during and after the treatment.

DRUG

Placebo

The participants will be administered 4 capsules of Lactose 500 mg (placebo) per oral route daily over 1 month.

Trial Locations (1)

91223

Institut de Recherche Biomédicale des Armées, Brétigny-sur-Orge

All Listed Sponsors
lead

Direction Centrale du Service de Santé des Armées

OTHER

NCT04549194 - Contribution of L-Tyrosine to Recovery From Operational Strain on Return From External Operation | Biotech Hunter | Biotech Hunter